On World Health Day, 7 April 2021, we will be inviting you to join a new campaign to build a fairer, healthier world. We’ll be posting more details here shortly, but here’s why we’re doing this:
Our world is an unequal one. As COVID-19 has highlighted, some people are able to live healthier lives and have better access to health services than others – entirely due to the conditions in which they are born, grow, live, work and age.
All over the world, some groups struggle to make ends meet with little daily income, have poorer housing conditions and education, fewer employment opportunities, experience greater gender inequality, and have little or no access to safe environments, clean water and air, food security and health services. This leads to unnecessary suffering, avoidable illness, and premature death. And it harms our societies and economies.
This is not only unfair: it is preventable. That’s why we are calling on leaders to ensure that everyone has living and working conditions that are conducive to good health. At the same time we urge leaders to monitor health inequities, and to ensure that all people are able to access quality health services when and where they need them.
COVID-19 has hit all countries hard, but its impact has been harshest on those communities which were already vulnerable, who are more exposed to the disease, less likely to have access to quality health care services and more likely to experience adverse consequences as a result of measures implemented to contain the pandemic.
WHO is committed to ensuring that everyone, everywhere, can realize the right to good health.
Nilaqua skin cleansing foam is a wonder for washing incontinence and all over the body without water. This is not an aerosol that dries the skin, but a kind and gentle water-based solution that really removes, dirt, faeces, urine, blood and iodine – without additional water or rinsing! In 2016 Nilaqua further developed this product to include antimicrobial properties that are effective against a huge number of pathogens including spores, bacteria and all enveloped viruses. Ideal for washing in isolation, staff before and after shifts, those with low immunity and wounds pre and post-op care.
To use simply apply directly to the area of the body i.e. leg, leave to activate for 30 seconds; gently massage to combine with the blood etc, then wipe off. Leaving soft clean skin.
These products are wonderful and already on the supply chain, please see codes: MRB1086 this is 200ml, 20 per case.
The Coronavirus crisis may be dominating the current news but for Weiss Technik, the task of controlling and containing viruses and bacteria started approximately 50 years ago when they introduced their first “Ultra Clean Ventilation” system (UCV). Originally developed for hospital theatre applications to contain airborne particles, Weiss Technik’s innovative UCV systems are now specified around the globe for situations where infection control and containment are critical health factors.
Rupert Mack is Weiss Technik’s director of strategic business area Mediclean and is a member of German DIN 1946 as well as European WG 18 TC 156 committee. Rupert has overseen the continuous development of a range of industry-leading products and solutions that help to combat the spread of viruses in commercial settings.
He commented, “The main source of microbial aerosols in enclosed spaces can be deemed to be from human and animal organisms. Indoor air pollution is an important problem because people inhale between 6–10 litres of air per minute, which amounts to 15,000 litres of air per day. The health risks from exposure to poor indoor air quality is therefore significant because we spend around 90% of the day in indoor environments, of which approximately 25%* is spent at work (*during normal circumstances).
“Ironically, traditional air conditioning systems can actually increase the potential for bacteria and viruses to survive over a long period of time and distance. As we have witnessed, there is a propensity for viruses to increase during the colder months, natural ventilation is reduced when the population typically spends more time indoors and utilises additional heating sources. Whilst these situations are well known, in the event of a pandemic, as we are experiencing now, one needs to focus on solutions that provide an exceptional level of protection.
“Whilst the issues are complex, there are two fundamental types of airflow when considering how airborne particles spread: we differentiate unidirectional airflow (laminar flow) and dilution mixing airflow (there’s a direct flow top-down scenario and also a head-to-head situation). So, for example, in a hospital operating theatre air purification is a must. Our UCV systems actually cleanse a specific part of the room; typically directly above and around the operating table. The process is enhanced through our “Weiss Mediclean” traffic light system which provides a clear visual reference to air flow and virus content. This links to a dynamic system that automatically adjusts the air flow to ensure continuous protection.
“Our systems offer a high level of sophistication in their design and functionality. They feature a highly effective HEPA filtration system, combined with UVC light. A HEPA (High Efficiency Particulate Absorber) filter is a specific type of high-quality air filter that meets the HEPOA filter standard, which is to remove at least 99.97% of particles (aerosols) from the air down to at least 0.3 microns in size. The UVC radiation is a known disinfectant for air, water, and nonporous surfaces. UVC radiation has effectively been used for decades to reduce the spread of bacteria, such as tuberculosis.
“The truth is that all indoor confined spaces now pose a potential threat. Businesses need robust, proven and reliable solutions that offer an unprecedented level of protection for their employees. Our product range has recently been augmented with the introduction of new products and solutions for every room or situation where people are working or living.
“Vindur® Top is an important development of our cooling system with HEPA filtration and UVC light and offers businesses the opportunity to easily retro-fit a unit into a building refurbishment situation or to have a complete building air purification system specified at the design and build stages. Vindur® Top is programmed to achieve 3 to 5 kilowatt cooling capacity that helps to counteract equipment that generates heat.
“We have just unveiled our latest product called Vindur® Pure. This is a mobile air purification system without cooling. This “plug and play” unit provides effective virus and bacteria control in rooms up to 70m2 capacity. It includes two filters (efficiency and high efficiency) and a UVC light. It can easily and simply be installed in a room, in ether a mobile floor standing or wall-mounted situation. Plus, when required, the unit can be switch to UCV operation only, to save energy. Vindur® Pure is an ideal solution for businesses looking for a fast and effective method of protecting their employees.
“As I have mentioned, Weiss Technik has almost five decades experience in developing bio-safety products and solutions. We are experts and help our customers specify precisely the right system for their circumstances. The factors are many and complex. Determining how to avoid infection from one person to another means calculating the correct level and type of air flow based on the number of people in a room and their movements. It means calculating how temperature changes influence these circumstances and how the type of flow of air is consequently affected.
“I am proud of the exceptional team here at Weiss Technik – a team of specialists who have developed a remarkable range of air purification products that meet the HTM 0301 UK accreditation and continue to set new and innovative standards of technical excellence”.
On a visit to a vaccination centre in West Yorkshire yesterday, the Prime Minister said restoring children’s education was the “biggest challenge” the government currently faces.
“We want to repair any damage or any loss, any detriment to kids’ education as fast as possible,” he added.
It comes after Professor Chris Whitty is understood to have told the PM that the peak of infections had been passed last week, according to the Telegraph.
Latest figures showed the virus has fallen to pre-New Year levels in every region of England, with the UK yesterday recording 18,607 new infections — a 30 per cent drop compared to the previous Monday.
The number of new infections in London has halved over the past 12 days, from 63,949 on the 15 January to 31,822 on the 27 January.
Ministers have insisted that Britain is on track to achieve its target of vaccinating the four most vulnerable groups by 15 February, and all over-18s by May.
Almost 9m people have been given their first dose of the jab so far, with a further 487,756 vaccines administered yesterday alone.
The NHS will start sending vaccine invites to around 3m people aged between 65 and 69 from next week.
However, the discovery of the South African variant cases around the UK has cast fresh doubts on the timeline of the UK’s return to normality.
Coronavirus cases have continued to fall in Suffolk and north Essex – but the infection rate in some districts remains higher than the national average.
Ipswich has the highest seven-day infection rate in Suffolk at 315.5 cases per 100,000 people in the week up to January 28 – though this represents a drop in cases from the week before.A Flourish chart
West Suffolk has the second-highest rate at 203.9, followed by East Suffolk’s rate of 184.4.
The rate in Mid Suffolk is 162.7, while Babergh’s infection rate is the lowest in the county at 148.9.
Infection rates remain comparatively high over the border in north Essex, with the seven-day rate recorded at 382.8 in Tendring in the same timeframe.
The scientific and pharmaceutical race to keep coronavirus vaccines ahead of new virus variants escalated Monday, even as a highly transmissible variant first detected in people who had recently travelled to Brazil was discovered in Minnesota.
Moderna, the maker of one of the two authorized coronavirus vaccines in the United States, announced it would develop and test a new vaccine tailored to block a similar mutation-riddled virus variant in case an updated shot becomes necessary.
The effort is a precautionary step. Evidence released Monday suggested that the Moderna vaccine will still work against two variants of concern that emerged in the United Kingdom and South Africa. The plan highlights that the scientists who responded with unprecedented speed and success to develop coronavirus vaccines are already moving to address new challenges. It also amplifies the urgency of getting as many people immunized with current vaccines as quickly as possible.
“We need to double down on public health measures. The less a virus spreads, the less it’s going to mutate,” said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases. “We need to get as many people vaccinated with the current vaccine that we have as we possibly can … and prepare for the potential eventuality that we might have to update this vaccine sometime in the future.”
The success of two remarkably effective coronavirus vaccines from Moderna and Pfizer-BioNTech in record time last year provided breathing room and hope, even as the pandemic surged. But the detection of variants in the United Kingdom, South Africa and Brazil in recent weeks raised immediate concern.
Those variants, each with a different assemblage of mutations, spread much more easily. But some of the mutations in each variant drew special concern because they sit in the spiky proteins that dot the outside of the coronavirus and have been the key target for vaccines and therapeutics.
Standard precautions to be applied during any vaccination activity are also valid for COVID-19 vaccine delivery, considering that the population to be vaccinated consists of individuals not presenting signs and symptoms of infection.
However, additional IPC precautions are necessary for the context of the COVID-19 pandemic to reduce the risk of SARS-CoV-2 transmission (e.g. mask use)
It is critical to provide health workers with specific training and the public with targeted
Preparation and planning phase
Appoint a facility IPC focal point8 for the planning, deployment and monitoring of the vaccination activities.
Identify an adequate number of vaccinators to ensure there is sufficient staff and time to support the correct implementation of the IPC practices required to safely administer the vaccine
Identify trained staff to deliver IPC training to those involved in vaccination activities (including managers, logisticians, vaccinators, cleaners and health workers dedicated to screening) and to provide information for clients to be vaccinated.
Identify health workers for the supervision of vaccination activities and define a monitoring and evaluation process of IPC practices, including providing feedback to vaccinators and other staff as required.
• All outer packaging must be removed and recycled before an item is taken onto any ward or clinical area. If this is taken into isolation or higher risk area, then it is likely to become contaminated and therefore must be disposed of as infectious clinical waste.
• All confidential waste must be put into confidential bins.
• All sharps and anatomical waste must be put into the relevant receptacle with an appropriately coloured lid as per HTM07-01, and these do not need to be put into an orange bag (https://www.gov.uk/government/publications/guidance-on-the-safe-management-of-healthcare-waste
• In summary, infectious clinical waste should be treated like any other infectious clinical waste – that is, as it would be for TB, hepatitis, etc, following national regulations. Healthcare waste is suitable for non-incineration technologies.
Hospitals in addition should ensure that:
• All food waste must be disposed of in black bags/compostable bags.
• Soiled linen must be put into alginate bags and then into relevant outer bags (usually white according to local policy)
• Non-ambulatory patients – urine and faeces to be put down the sluice/toilet. Where no sluice/toilet is available, excreta may be gelled and disposed of in an orange bag. If bed-bound, urine from catheter taken to sluice/toilet. The use of these granules must be strictly controlled as described in this NHS National Patient Safety Alert; https://www.england.nhs.uk/publication/patient-safety-alert-superabsorbent-polymer-gel-granules/. Ambulatory patients can go to the toilet as normal were safe and feasible to do so.
• Where medicines are prepared in a clean area, pharmaceutical waste must be separated into the following receptacles: – Blue – non-hazardous healthcare medicines for incineration
– Purple – waste contaminated with cytotoxic and cytostatic medicines for incineration.
• Waste should be bagged in the appropriate colour bag. Where clinical waste carts are used, the bagged waste must be put into carts awaiting collection and disposal. Please ensure that all bins are full before releasing them from site.
• Disposal of all waste related to possible or confirmed cases should be classified as an infectious clinical waste suitable for alternative treatment and transported as category B, unless the waste has other properties that require it to be incinerated.
• No domestic waste is to be sent directly to landfill from acute hospital settings.
• Confidential waste generated on all wards (including isolation wards) must be disposed of via the existing confidential waste route. Confidential waste bins from areas with positive COVID-19 patients should be left for 72 hours before their contents is shredded
Contaminated ultrasound gel has been associated with outbreaks of infection in various settings and identified as a potential vector for infection.[1-9] Standard ultrasound gel is not produced as a sterile product. Ultrasound and ultrasound-guided procedures are conducted routinely both in radiology and clinical areas, including use in high dependency care and among patients with immunosuppression. There is currently little available guidance on good practice in use of ultrasound gel for the UK setting.
This document provides interim guidance on the safe use of ultrasound gel to reduce risk of transmission of infection. It has been in part adapted from guidance produced elsewhere and should be considered in the wider context of standard infection prevention and control precautions.[10,11]
Which type of ultrasound gel to use
Sterile ultrasound gel must be used:
for invasive procedures, that is any ultrasound-guided procedure that involves passing a device through tissue such as intravenous line insertion or fine needle aspirate (this includes ‘viewing/initial assessment’ of the site by ultrasound prior to undertaking an aseptic procedure)
where there is contact with non-intact skin
where there is contact with mucous membrane (for example for transrectal or transvaginal procedures)
for examinations on immunocompromised, neonatal intensive care or critically ill hospitalised patients (such as in high-dependency or intensive-care settings)
Non-sterile ultrasound gel may be used:
during low risk, general examinations on intact skin, not relating to a procedure or immediately prior to a procedure
Safe use of ultrasound gel
For sterile ultrasound gel:
ensure that only unopened sachets and containers that are labelled as ‘sterile’ are used
do not reuse once opened, either with other patients or stored and reused with the same patient, as sterile gels are single-use only
For non-sterile ultrasound gel:
we recommend use of pre-filled bottles in preference to re-filling reusable bottles
remove gel from skin after the procedure using a clean paper towel, tissue or wipe and clean or cleanse the skin using patient skin wipes or equivalent
nozzles of bottles should not come into contact with the patient, staff or instruments
if the nozzle comes into contact with the patient’s skin, the bottle should be discarded
Ensure to check and only use products within their expiry date and discard any product that has exceeded expiry or has exceeded the manufacturer’s recommended time after opening.